Patients undergoing plastic surgery often have higher rates of psychiatric disorders, which may influence surgical outcomes and quality of life (QoL). A retrospective review of patients with and without psychiatric comorbidities who underwent reduction mammoplasty or body contouring (panniculectomy and/or abdominoplasty) from 2016 to 2022 was conducted. Propensity-score matching considered age, BMI, ethnicity, bariatric surgery history, ptosis, and breast tissue mass. Demographics, clinical characteristics, and postoperative outcomes were compared. QoL was assessed using pre- and postoperative BREAST-Q and BODY-Q. A literature review using PubMed, MEDLINE, Embase, Scopus, and COCHRANE databases was performed on surgical outcomes of patients with psychiatric disorders undergoing plastic surgery. Among 554 patients, 194 underwent body contouring (97 with and 97 without psychiatric diagnoses), and 360 had reduction mammoplasties (180 each). Body contouring patients averaged 46.7 years with a BMI of 31.2; psychiatric comorbidities were linked to increased surgical site occurrences (AOR 3.02) and longer hospital stays (AOR 1.73). Reduction mammoplasty patients averaged 36.3 years with a BMI of 29.7; psychiatric comorbidities predicted more readmissions and ED visits (AOR 4.86). Both groups showed improved postoperative QoL, regardless of psychiatric status. All 7 studies included in the literature review reported higher complication rates in patients with psychiatric diagnoses. Psychiatric comorbidities are associated with higher complication rates and healthcare utilization in plastic surgery. Nonetheless, these patients observe comparable postoperative QoL improvements, underscoring the benefit of these procedures. Appropriate pre- or post-operative interventions should be considered to optimize outcomes and satisfaction in this vulnerable patient population.
Amro et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: